Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
9,170,973
-
Shares change
-
+3,745,835
-
Total reported value, excl. options
-
$478,909,682
-
Value change
-
+$200,541,364
-
Number of buys
-
128
-
Number of sells
-
-25
-
Price
-
$52.16
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2020
174 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q2 2020.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,170,973 shares
.
Largest 10 shareholders include MORGAN STANLEY (1,507,895 shares), UBS Group AG (927,637 shares), Carroll Financial Associates, Inc. (471,996 shares), MAINSTAY CAPITAL MANAGEMENT LLC /ADV (404,073 shares), LPL Financial LLC (394,570 shares), WELLS FARGO & COMPANY/MN (376,366 shares), BANK OF AMERICA CORP /DE/ (324,489 shares), COMMONWEALTH EQUITY SERVICES, LLC (304,666 shares), Claraphi Advisory Network, LLC (266,235 shares), and Legend Financial Advisors, Inc. (252,375 shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.